Actively Recruiting
CFTR Modulators in Pregnancy and Postpartum
Led by Region Stockholm · Updated on 2024-03-08
75
Participants Needed
1
Research Sites
776 weeks
Total Duration
On this page
Sponsors
R
Region Stockholm
Lead Sponsor
K
Karolinska Institutet
Collaborating Sponsor
AI-Summary
What this Trial Is About
Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.
CONDITIONS
Official Title
CFTR Modulators in Pregnancy and Postpartum
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Woman with cystic fibrosis who is pregnant and treated with Kaftrio
- Newborn infant to the above mentioned woman
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stockholm CF center
Stockholm, Sweden
Actively Recruiting
Research Team
J
jenny svedenkrans
CONTACT
T
Terezia Pinzikova
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here